Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Mini Review
Cognitive Impairment in Chronic Kidney Disease-Prevalence, Mechanisms and Consequences
Janine Gronewold and Dirk M Hermann*Department of Neurology, University Hospital Essen, Essen, Germany
- *Corresponding Author:
- Dirk M Hermann
Department of Neurology, University Hospital Essen
Essen, Germany
Tel: 00491738619678
E-mail: dirk.hermann@uk-essen.des
Received date: May 19, 2017; Accepted date: May 29, 2017; Published date: June 05, 2017s
Citation: Gronewold J, Hermann DM (2017) Cognitive Impairment in Chronic Kidney Disease-Prevalence, Mechanisms and Consequences. J Alzheimers Dis Parkinsonism 7:331. doi:10.4172/2161-0460.1000331
Copyright: © 2017 Gronewold J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
In ageing populations, chronic kidney disease (CKD) gets an increasing health problem worldwide. While current therapy of CKD mostly focusses on kidney function and cardiovascular comorbidity, cognition, which crucially influences adherence to CKD therapy, is often neglected. Prevalence of cognitive impairment is high in CKD, ranging from 17% to 87%, depending on CKD severity and cognitive domain affected. In contrast to Alzheimer’s disease patients, which often show impairment in memory function, CKD patients present with a broader spectrum of cognitive deficits, namely impairment in executive function, information processing, language and visuoconstruction which is usually mild in early CKD stages but advances with CKD progression and progression of comorbidities. Mechanisms underlying cognitive impairment in CKD are discussed and conclusions are derived how cognitive impairment may be prevented in CKD and, if cognitive deficits are present, how cognitive impairment may be taken into consideration in patient management.
